Simpson Todd E - Insider Stock Trading - OpenInsider

CIK: 1216477 - Address: 21823 30Th Dr. Se, Bothell, WA 98021

13 results

TC	Stat	Stk	Ins	Fil	+d	+w	+m	+q	+h	+y	avg

Filing Date	T Date	Ticker	Issuer	Inc	Sector	Ind	Industry	Owner	oSt	Rel	Title	T	TVal	Price	L	Qty	oc	Own	H	r2y	r1y	r6m	r3m	r6w	r3w	r7d	r3d	f1d	f1w	f1m	f3m	f6m	f1y
9/22/23 19:45	9/21/23	SGEN	Seagen Inc.	WA	Health	BioPrd	Biological Products, (No Diag	Simpson Todd E	WA	O	CFO	S	-17	206.50	0	0	0	129	D
9/1/23 16:49	8/31/23	SGEN	Seagen Inc.	WA	Health	BioPrd	Biological Products, (No Diag	Simpson Todd E	WA	O	CFO	S	-439	206.97	0	-2	-2	129	D
8/30/23 19:06	8/29/23	SGEN	Seagen Inc.	WA	Health	BioPrd	Biological Products, (No Diag	Simpson Todd E	WA	O	CFO	S	-100	206.00	0	0	0	131	D
4/12/23 19:50	4/10/23	SGEN	Seagen Inc.	WA	Health	BioPrd	Biological Products, (No Diag	Simpson Todd E	WA	O	CFO	M.d	2,566	46.37	0	55	87	119	D
4/12/23 19:50	4/10/23	SGEN	Seagen Inc.	WA	Health	BioPrd	Biological Products, (No Diag	Simpson Todd E	WA	O	CFO	S.d	-11,322	204.58	0	-55	-32	119	D
4/7/23 19:40	4/6/23	SGEN	Seagen Inc.	WA	Health	BioPrd	Biological Products, (No Diag	Simpson Todd E	WA	O	CFO	S	-50	205.86	0	0	0	119	D
3/10/23 16:11	3/9/23	SGEN	Seagen Inc.	WA	Health	BioPrd	Biological Products, (No Diag	Simpson Todd E	WA	O	CFO	M.d	1,939	45.30	0	43	58	117	D
3/10/23 16:11	3/9/23	SGEN	Seagen Inc.	WA	Health	BioPrd	Biological Products, (No Diag	Simpson Todd E	WA	O	CFO	S.d	-7,558	176.61	0	-43	-27	117	D
2/28/23 19:24	2/27/23	SGEN	Seagen Inc.	WA	Health	BioPrd	Biological Products, (No Diag	Simpson Todd E	WA	O	CFO	S	-3,651	182.53	0	-20	-15	117	D
2/21/23 19:35	2/16/23	SGEN	Seagen Inc.	WA	Health	BioPrd	Biological Products, (No Diag	Simpson Todd E	WA	O	CFO	M.d	1,564	39.15	0	40	41	137	D
2/21/23 19:35	2/16/23	SGEN	Seagen Inc.	WA	Health	BioPrd	Biological Products, (No Diag	Simpson Todd E	WA	O	CFO	S.d	-6,391	160.00	0	-40	-23	137	D
9/1/22 18:09	8/31/22	SGEN	Seagen Inc.	WA	Health	BioPrd	Biological Products, (No Diag	Simpson Todd E	WA	O	CFO	S	-646	154.42	0	-4	-3	137	D
8/17/22 21:19	8/16/22	SGEN	Seagen Inc.	WA	Health	BioPrd	Biological Products, (No Diag	Simpson Todd E	WA	O	CFO	S	-335	170.22	0	-2	-1	141	D

D	Derivative transaction in filing (usually option exercise)
M	Multiple transactions in filing; earliest reported transaction date and weighted average transaction price
A	Amended filing
E	Error detected in filing

S - Sale	Sale of securities on an exchange or to another person
S - Sale+OE	Sale of securities on an exchange or to another person (after option exercise)
F - Tax	Payment of exercise price or tax liability using portion of securities received from the company
P - Purchase	Purchase of securities on an exchange or from another person

Return to top

Contact